Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Mar 09, 2023 11:00pm
122 Views
Post# 35329752

Brain spinal cord and neurons

Brain spinal cord and neurons
Yes, you are correct. Neurodegenerative disorders such as ALS (Amyotrophic Lateral Sclerosis), Parkinson's disease, multiple sclerosis, and others are characterized by the progressive degeneration and death of nerve cells in the brain and/or spinal cord.
 
One of the common features of these disorders is the degradation of the myelin sheath that surrounds and protects nerve fibers. The myelin sheath is a fatty, insulating layer that allows nerve impulses to travel quickly and efficiently along the nerve fibers.
 
In ALS, the myelin sheath around the nerve fibers that control muscle movement is gradually destroyed, leading to muscle weakness, stiffness, and eventually paralysis.
 
In Parkinson's disease, the myelin sheath in the brain that surrounds the nerve fibers that produce the neurotransmitter dopamine is damaged, leading to the characteristic motor symptoms of tremors, rigidity, and slowness of movement.
 
In multiple sclerosis, the immune system attacks and damages the myelin sheath in the brain and/or spinal cord, leading to a wide range of neurological symptoms such as muscle weakness, numbness, and difficulty with balance and coordination.
 
Overall, the degradation of the myelin sheath in these neurodegenerative disorders is thought to play a key role in the progressive loss of nerve function and the development of symptoms.
<< Previous
Bullboard Posts
Next >>